Biobijou Co

Biobijou Co EBIT Margin

The EBIT Margin (Operating Margin) of Biobijou Co (489460.KQ) as of Oct 30, 2026 is 14.84 %. In the previous year, EBIT Margin (Operating Margin) was 31.14 % — a change of -52.35% (lower).

EBIT Margin

14.84 %

YoY

-52.35%

Last updated:

EBIT Margin (Operating Margin) of Biobijou Co is 2025 14.84 % . EBIT Margin (Operating Margin) of Biobijou Co was 2024 31.14 % . It decreases by -52.35% lower compared to the previous year.

For Biobijou Co, the operating (EBIT) margin of 14.9% is down versus 17.7% a few years ago.

The Biobijou Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2022
17.28 KRW
Jan 1, 2023
30.15 KRW
Jan 1, 2024
31.14 KRW
Jan 1, 2025
14.84 KRW
The Biobijou Co EBIT Margin history
YEAREBIT MarginYoY
14.84 %-52.35%
31.14 %+3.27%
30.15 %+74.50%
17.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biobijou Co Stock analysis

What does Biobijou Co do? Biobijou Co Ltd is a South Korean pharmaceutical company based in Hanam, Gyeonggi-Do, operating within the Health Care sector. The company focuses on the research, development, manufacturing, and sale of skin booster and filler products utilizing hyaluronic acid and various materials for the global aesthetic market. It also produces cosmetic products including masks, mists, and creams. Biobijou Co Ltd completed its initial public offering on May 20, 2025, with the ticker symbol 489460.KQ and ISIN KR74860006. The company's website is http://www.biobijou.co.kr. It operates as an export-oriented business, targeting international markets for its aesthetic and cosmetic product lines. The firm's primary activities involve the production and distribution of hyaluronic acid-based skin care solutions and related cosmetic items. As a newly listed entity, Biobijou Co Ltd is positioned within the pharmaceutical and cosmetic industries, emphasizing innovation in aesthetic treatments. The company's operations are centered in Hanam, South Korea, with an emphasis on global market expansion through its export strategy. Biobijou Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biobijou Co stock

EBIT Margin (Operating Margin) of Biobijou Co is 14.84 % in 2025.

EBIT Margin (Operating Margin) of Biobijou Co changed from 31.14 % to 14.84 %, representing a -52.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Biobijou Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Biobijou Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Biobijou Co

All Key Metrics — Biobijou Co